Welch Allyn
Overview
Welch Allyn is a global manufacturer of medical diagnostic equipment and patient monitoring systems. Founded in 1915, the company has a long history of innovation in the medical device industry. In 2015, Welch Allyn was acquired by Hill-Rom, a leading provider of medical technologies, for $2 billion. Hill-Rom was subsequently acquired by Baxter International in 2021, further expanding Welch Allyn's reach and capabilities in the healthcare sector. As a corporate venture capital arm, Welch Allyn has engaged in strategic investments to advance its organizational interests. Notably, in 2014, the company led a $7 million Series B investment round in Cardiac Insight, a University of Washington spinoff specializing in advanced body-worn sensing and computing technologies for cardiology and respiratory applications. This investment underscores Welch Allyn's commitment to integrating innovative technologies into its product offerings. Welch Allyn's investment strategy focuses on early-stage and growth-stage companies within the medical devices and healthcare technologies sectors. By investing in these areas, the company aims to enhance its product portfolio and maintain its position as a leader in providing comprehensive diagnostic solutions. The company's investments are geographically diverse, reflecting its global presence and commitment to advancing healthcare worldwide.
Investment Focus
- Innovative medical device technologies
- Advanced patient monitoring solutions
- Healthcare technology startups with growth potential
- Companies with a focus on improving patient care and outcomes
- Early-stage and growth-stage companies in the healthcare sector
- Startups with a strong research and development focus
- Companies with scalable business models
- Innovative solutions in diagnostics and patient monitoring
- Technologies that align with Welch Allyn's product portfolio
- Companies with a global market reach
- Startups with experienced management teams
- Companies with a clear regulatory strategy
- Innovative solutions in telemedicine and health IT
- Companies with a focus on patient-centric care
- Startups with a strong intellectual property portfolio
- Companies with a commitment to quality and safety standards
- Innovative solutions in medical imaging
- Companies with a focus on surgical instruments
- Startups with a strong clinical research component
- Companies with a focus on medical supplies and healthcare services
Portfolio Companies
Reach Welch Allyn directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Welch Allyn
What sectors does Welch Allyn invest in?
Welch Allyn invests in Technology, Healthcare, Healthcare Services, Pharmaceuticals, Medical Devices and Diagnostics, and is based in Skaneateles Falls, New York, United States. Welch Allyn is listed as a corporate vc in the ConnectSafely investor database.
What stage does Welch Allyn invest at?
Welch Allyn backs companies at Early Stage and Growth, writing cheques of 7M - 20M.
Which regions does Welch Allyn invest in?
Welch Allyn invests across United States, Australia, Europe, Asia, Middle East and South Asia.
Who are the partners at Welch Allyn?
Team members listed for Welch Allyn include Jack Disarro (Vice President, Channel Management /Strategic Markets-Retired) and Andy Clapper (Senior Vice President, Global Operations and Supply Chain Management).
What companies has Welch Allyn invested in?
Welch Allyn's portfolio includes EarlySense and Cardiac Insight.
How do I contact Welch Allyn?
Welch Allyn's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
